Simcere Pharma

About:

Simcere Pharma is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market.

Website: http://simcere.com

Top Investors: GP Capital, Hony Capital, Jolmo Capital, CITIC Securities, Yingke Capital

Description:

Founded on 28th March 1995, Simcere swiftly evolved from being a pure distributor of pharmaceutical products to become a leading manufacturer and supplier of drugs in China's rapidly growing pharmaceutical market. Simcere currently operates five GMP-certified manufacturing facilities, two nationwide sales and marketing subsidiaries, a research and development center and manages over 4,000 employees. They are the first Chinese chemical and biological drug company to list on the New York Stock Exchange with IPO proceeds reaching US$ 261 million.

Total Funding Amount:

1.57B CNY

Estimated Revenue Range:

$1B to $10B

Headquarters Location:

Nanjing, Jiangsu, China

Founded Date:

1995-01-01

Contact Email:

simcere(AT)simcere.com

Founders:

Jinsheng Ren

Number of Employees:

1001-5000

Last Funding Date:

2024-02-27

IPO Status:

Public

Industries:

© 2025 bioDAO.ai